Bavarian Nordic A/S - Report on the Results of the Annual

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Apr 24, 2014 at 1:00 PM

Bavarian Nordic A/S - Report on the Results of the Annual General Meeting, held 24 April 2014

KVISTGÅRD, Denmark - April 24, 2014 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today held the Annual General Meeting with the results as follows: * The Annual Report for 2013 was adopted. The Board of Directors' proposal to transfer the Company's result to next year was also adopted. * The General Meeting adopted a resolution to discharge the Board of Directors and the Board of Management from their obligations. * Gerard van Odijk, Claus Bræstrup, Anders Gersel Pedersen, Erik G. Hansen and Peter Kürstein were re-elected to the Board of Directors. The Chairman of the Board, Asger J. Aamund has chosen not to be nominated for re-election. The Board of Directors constituted itself with Gerard van Odijk as Chairman. * Deloitte Statsautoriseret Revisionspartnerselskab was re-elected as auditors. * The proposal to extend the Board of Directors authorization to increase the share capital of the Company until 30 June 2015 was adopted. * The proposal to increase and extend the Board of Directors authorization for issuing Warrants was adopted. * The suggested remuneration of the Board of Directors for the current financial year was approved. * The Board of Directors was authorized to let the Company purchase its own shares. * The proposal to change the Company's corporate language to English was approved. * The proposal that future general meetings may be held in either Danish or English as resolved by the Board of Directors, and that documents prepared for use by general meetings may also be prepared in Danish or English as resolved by the Board of Directors was approved. * The proposal that the Company's annual reports and interim financial reports going forward are only prepared in English was approved. * The proposal to adopt new general guidelines for incentive remuneration of the board and management in Bavarian Nordic A/S was approved. Anders Hedegaard, President & CEO. Contacts Rolf Sass Sørensen, Vice President Investor Relations (EU). Phone +45 61 77 47 43 Seth Lewis, Vice President Investor Relations (US). Phone + 1 978-298-5654 About Bavarian Nordic Bavarian Nordic is an international biotechnology company developing and manufacturing novel cancer immunotherapies and vaccines for infectious diseases. Lead product candidates are PROSTVAC®, an immunotherapy product candidate for advanced prostate cancer that is the subject of an ongoing pivotal Phase 3 clinical trial and IMVAMUNE®, a non-replicating smallpox vaccine candidate in Phase 3 development, which is being developed and supplied for emergency use to the U.S. Strategic National Stockpile under a contract with the U.S. Government. The vaccine is approved in Canada under the trade name IMVAMUNE and in the European Union under the trade name IMVANEX®. Bavarian Nordic's shares are listed on NASDAQ OMX Copenhagen under the symbol BAVA (Reuters: BAVA.CO, Bloomberg: BAVA.DC). The company has a sponsored Level 1 ADR program listed in the US (OTC) under the symbol BVNRY. For more information, visit www.bavarian-nordic.com. Forward-looking statements This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law. [HUG#1779854]

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cars.com Inducement Awards: New CPO Earns Stock Boost

Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...

Edgewise Therapeutics' Investor Play: What's the Buzz?

Edgewise Therapeutics Maps Out Investor Terrain Alright, Edgewise Therapeutics, folks. They're shaking things up, and I mean that literally and figuratively. This clinical-stage cardiac biotech isn’t just sitting on its hands; they're out there hustling at the Guggenheim 3rd Annual Healthcare Innovation Conference. Buckle up, because the heart of their...

Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Global Museum of Illusions Comes to San Francisco

Illusions on Market Street The Global Museum of Illusions, the fast-growing sensation in private museums, is setting its sights on San Francisco with a new location opening on Market Street this November 13. They're dangling a juicy 50% off presale ticket offer for the early birds. A Mind-Bending Experience This museum isn't your run-of-the-mill art gallery or historical...

ASMAX Unleashes Next-Level Motorcycle Comms at EICMA

Transforming the Motorcycle Communication Landscape Motorcycling ain't just about the roaring engines and the rubber on the road. In the world of helmets and handlebars, some bright minds are weaving tech magic at the EICMA 2026 in Milan. ASMAX has rolled out its shiny new RoamX intercom gadget, leaving folks buzzing at Hall 6. What RoamX Brings to the Table This ain't...

Bybit Shines at Web Summit 2026 as AI Takes Center Stage

Financial Revolution: Bybit Steals the Spotlight Ever been to a tech show where financial bigwigs mingle with code geeks? Well, that's exactly the scene unfolding at the famed Web Summit 2026, with Bybit throwing down the gauntlet as an official partner. The MEO Arena in Lisbon is buzzing more than a stock ticker on a rollercoaster day, as Bybit flaunts its wares to a...

Stocks Jump Ahead of Critical Inflation Reports

Stocks Lift as Wall Street Awaits Inflation Data Every trader's favorite game—speculation—returns as major U.S. stock benchmarks kick off Monday with some gusto. The S&P 500, Nasdaq Composite, Dow Jones Industrial Average, and Russell 2000 all saw gains in the early morning session, signaling positive vibes across the board. Numbers don't lie, folks: The S&P climbed...

INDOCHINO Expands into South Jersey with New Showroom

Cherry Hill's New Tailored Suit Destination Amidst the hustle and bustle of South Jersey, INDOCHINO has flung open the doors of its latest showroom at Cherry Hill Mall, promising a blend of custom luxury at a palatable price. This ain't just any cookie-cutter suit store — it's the second of INDOCHINO's new concept stores, cooking up something unique for sartorial...

New Metrics Aim to Elevate Organ Procurement Performance

Revamping Organ Procurement: A New Approach In the tangled web of healthcare, the organ donation system stands as a lifeline that's often tangled in its metrics. The latest stride by the Association of Organ Procurement Organizations (AOPO) might put some untethered efforts in line. With an announcement on November 9, 2026, the AOPO unveiled three fresh performance...

Children's Institute Gala Raises $4M: A Night to Remember

Breaking Records and Honoring Legends You know, sometimes there's more to the world than stocks and ticker tapes. Over in Los Angeles, the Children's Institute pulled off a real spectacle with their Annual Cape & Gown Gala, drawing in more than 600 folks and raking in a whopping $4 million. That's right, four million clams in one evening—a record-breaker for them. When...